Precision medicine: Targeted therapies
Breast cancer is divided in three main groups according to the main receptors on the surface of the cancer cells: ER+ (oestrogen receptor positive), Her2+ and Triple Negative Breast Cancer (TNBC). There are groups of treatment that target these receptors accordingly making treatment precise, targeted, less toxic and more efficient.
Immunotherapy for example allows patients’ immune systems to fight cancer. It works by harnessing/empowering the immune system to recognise and kill cancer cells. We also have oestrogen blockers and anti Her2 inhibitors, which are incredibly effective.
These drugs can be used to treat specific subgroups of breast cancer before, after surgery or in people with secondary breast cancer (breast cancer elsewhere in the body).
Find out more at the links below: